Combination therapy of anti-cancer bioactive peptide with Cisplatin decreases chemotherapy dosing and toxicity to improve the quality of life in xenograft nude mice bearing human gastric cancer

BACKGROUND: A great challenge of cancer chemotherapy is to eliminate cancer cells and concurrently maintain the quality of life (QOL) for cancer patients. Previously, we identified a novel anti-cancer bioactive peptide (ACBP), a peptide induced in goat spleen or liver following immunization with hum...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Xiulan, Dong, Chao, Zhang, Jialing, Su, Liya, Wang, Xuemei, Cui, Hongwei, Chen, Zhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3930002/
https://www.ncbi.nlm.nih.gov/pubmed/24507386
http://dx.doi.org/10.1186/2045-3701-4-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3930002/
https://www.ncbi.nlm.nih.gov/pubmed/24507386
http://dx.doi.org/10.1186/2045-3701-4-7

Ejemplares similares